<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31596" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hyperbaric Therapy in Blood Loss Anemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Johnson-Arbor</surname>
            <given-names>Kelly</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cooper</surname>
            <given-names>Jeffrey S.</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kelly Johnson-Arbor declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jeffrey Cooper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31596.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Red blood cells contain hemoglobin, the primary carrier of oxygen throughout the human body. When hemoglobin levels decrease, anemia results and patients may exhibit signs and symptoms of decreased oxygen delivery to tissues (also known as oxygen debt). The signs and symptoms of oxygen debt may include tachycardia, dyspnea, fatigue, chest pain, and altered mental status. Laboratory findings may include metabolic acidosis, hyperlactatemia, and elevated cardiac enzymes. Transfusion of packed red blood cells is administered to anemic patients who are symptomatic to relieve the signs and symptoms of oxygen debt. However, some patients are unable to receive blood transfusions due to religious beliefs or medical reasons. In these patient populations, hyperbaric oxygen therapy can be administered to increase oxygen delivery to tissues and relieve the signs and symptoms of oxygen debt. This activity highlights the interprofessional team's role in managing patients with anemia who refuse blood transfusions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review reasons why some patients cannot accept blood transfusions.</p></list-item><list-item><p>Summarize the use of hyperbaric oxygen therapy for anemic patients.</p></list-item><list-item><p>Describe the adverse effects of hyperbaric oxygen treatments.</p></list-item><list-item><p>Explain modalities to improve care coordination among interprofessional team members to improve outcomes for patients affected by anemia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31596&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31596">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31596.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Red blood cells contain hemoglobin, the primary carrier of oxygen throughout the human body. When hemoglobin levels decrease, anemia results, and patients may exhibit signs and symptoms of reduced oxygen delivery to tissues (also known as oxygen debt).<xref ref-type="bibr" rid="article-31596.r1">[1]</xref> The signs and symptoms of oxygen debt may include tachycardia, dyspnea, fatigue, chest pain, and altered mental status. Laboratory findings may include metabolic acidosis, hyperlactatemia, and elevated cardiac enzymes. Transfusion of packed red blood cells is administered to anemic patients who are symptomatic to relieve the&#x000a0;signs and symptoms of oxygen debt. However, some patients cannot receive blood transfusions due to religious beliefs or medical reasons such as massive autoimmune hemolysis.<xref ref-type="bibr" rid="article-31596.r1">[1]</xref> In these patient populations, hyperbaric oxygen therapy can increase oxygen delivery to tissues and relieve the signs and symptoms of oxygen debt.</p>
      </sec>
      <sec id="article-31596.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>According to the Jehovah&#x02019;s Witnesses religion, portions of the Bible (including Genesis, Leviticus, and Acts) state that its followers must abstain from receiving blood.<xref ref-type="bibr" rid="article-31596.r2">[2]</xref> Jehovah&#x02019;s Witnesses will not accept blood transfusions, and this religious belief has been upheld in the American legal system.<xref ref-type="bibr" rid="article-31596.r2">[2]</xref></p>
        <p>Other patients are unable to accept blood products due to medical reasons. Examples include patients with hemolysis and antibody formation due to transfusion reactions or those with crossmatch incompatibility.&#x000a0;</p>
        <p>Patients who cannot accept blood transfusions for medical or religious purposes are at increased risk of morbidity and death after acute and unexpected blood loss from conditions including postpartum bleeding, trauma, and intraoperative hemorrhage.</p>
      </sec>
      <sec id="article-31596.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Up to 1000 Jehovah's Witnesses die each year in part because they refuse to accept a blood transfusion.<xref ref-type="bibr" rid="article-31596.r2">[2]</xref> Anemic patients who are elderly, obese, on hemodialysis, or have underlying heart disease are at increased risk for mortality.</p>
      </sec>
      <sec id="article-31596.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hyperbaric oxygen therapy is delivered in a hyperbaric (pressure) chamber with the patient&#x000a0;breathing 100% oxygen at a pressure greater&#x000a0;than 1.0 atmosphere absolute (ATA). Typically 2-3 ATA is used. Beyond 3 ATA, there are issues with oxygen toxicity.&#x000a0;&#x000a0;&#x000a0;</p>
        <p>The amount of oxygen delivered to the body (DO2) is dependent on the arterial oxygen content (CaO2) and cardiac index (CI). The equation representing this is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>DO2 = CaO2 x CI</p>
          </list-item>
        </list>
        <p>The&#x000a0;arterial oxygen content primarily depends on hemoglobin concentration; each hemoglobin molecule can carry up to 1.38 ml of oxygen per gram of hemoglobin.<xref ref-type="bibr" rid="article-31596.r3">[3]</xref> A tiny amount of the arterial oxygen supply is dissolved in the plasma and depends on the partial pressure of oxygen in the blood (PaO2). The following equation represents the arterial oxygen content:</p>
        <list list-type="bullet">
          <list-item>
            <p>CaO2= (Hemoglobin [g/dL] x 1.38 ml O2 x %oxygen saturation) + (0.003 x PaO2)</p>
          </list-item>
        </list>
        <p>The oxygen delivered to tissues is then extracted and used by the tissues. On average, the human body extracts 5% to 6% volume of oxygen from the blood.<xref ref-type="bibr" rid="article-31596.r3">[3]</xref> As long as the oxygen supply equals or exceeds the amount of extracted oxygen, symptoms of oxygen debt do not occur. In anemic patients, oxygen delivery via hemoglobin may not be sufficient to compensate for oxygen extraction. When hemoglobin concentrations drop below 6 g/dL, oxygen delivery, and extraction become unequal, and when hemoglobin concentrations fall below 4 g/dL, tissue oxygenation delivery is significantly impaired.<xref ref-type="bibr" rid="article-31596.r2">[2]</xref></p>
        <p>In 1959, the Dutch surgeon Boerema published &#x0201c;Life Without Blood,&#x0201d; a manuscript detailing the use of hyperbaric oxygen therapy (HBO) for treating anemia.<xref ref-type="bibr" rid="article-31596.r4">[4]</xref> Boerema exsanguinated healthy piglets and replaced the blood volume with a plasma-like solution. The piglets&#x02019; resulting hemoglobin concentration was 0.4 g/dL, which is incompatible with life. The piglets were then pressurized in a hyperbaric chamber to 3 absolute atmospheres (ATA) for 45 minutes. The animals survived this exposure, despite having essentially no hemoglobin present and recovered uneventfully after they were re-infused with normal blood. Boerema noted that under hyperbaric conditions, the amount of oxygen dissolved in the plasma could significantly exceed the amount present while breathing air under normobaric conditions. This phenomenon is due to Henry&#x02019;s Law, which states that the amount of gas dissolved in a solution is directly proportional to the partial pressure of the gas. When partial pressures of a gas increase, such as under hyperbaric pressurization, more of that gas dissolves in solution. Breathing room air (21% oxygen) under normobaric conditions results in a PaO2 of approximately 100 mmHg; breathing 100% oxygen under hyperbaric conditions results in a PaO2 greater than 2000 mmHg. Under hyperbaric conditions, oxygen dissolved in the plasma can approximate or meet the body&#x02019;s metabolic demands of oxygen extraction.<xref ref-type="bibr" rid="article-31596.r5">[5]</xref>&#x000a0;At a treatment depth of 3 ATA, the plasma dissolved oxygen approximates 6% volume, equal to the body&#x02019;s oxygen extraction.<xref ref-type="bibr" rid="article-31596.r6">[6]</xref></p>
      </sec>
      <sec id="article-31596.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Anemia can present with a wide range of&#x000a0;signs and symptoms. For example, anemic patients may be light-headed, confused,&#x000a0;weak, fatigued, irritable, and have headaches,&#x000a0;decreased exercise tolerance, palpitations, or dyspnea. Generally, symptoms do not occur until&#x000a0;the hemoglobin level drops to less than 7 g/dL.&#x000a0;&#x000a0;</p>
        <p>The most common systems involved in hemorrhage are the gastrointestinal, genitourinary, and pulmonary systems. Therefore, menstrual history in women should be explored, as well as asking about&#x000a0;hematemesis, hemoptysis, hematuria, hematochezia, and melena.</p>
        <p>A thorough past medical history should include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Medications such as aspirin, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, bisphosphonates,carbamazepine, cephalosporins, nonsteroidal anti-inflammatory drugs,&#x000a0;phenytoin, sulfa drugs, and chemotherapy agents</p>
          </list-item>
          <list-item>
            <p>Supplements such as iron, folate, and B12,</p>
          </list-item>
          <list-item>
            <p>Family history such as Sickle cell anemia, glucose-6-phosphate deficiency, spherocytosis</p>
          </list-item>
        </list>
        <p>On exam, signs of acute blood loss associated with emergent anemia can include hemodynamic abnormalities such as hypotension, tachycardia, and tachypnea. In addition, the patient may experience decreased urine output, increased thirst, and altered mental status. These clinical manifestations depend on factors such as patient comorbidities, age, baseline medications, and severity of illness or injury. For example, younger adults may be able to compensate with an increased heart rate. However, older patients with baseline medical problems are more commonly unable to&#x000a0;compensate. This may be especially true if they are chronically on beta-blockers. The examination is often normal in patients with chronic anemia, although several findings suggest specific causes. Pallor, scleral icterus, and jaundice are associated with hemolytic anemia.</p>
        <p>In addition, physicians should assess for evidence of cardiac murmur, crackles, hepatomegaly or splenomegaly, thyromegaly, and lymphadenopathy. On rectal examination, evaluation for tenderness, joint deformities, rashes, and melena or blood is essential. Evidence of bleeding with chronic anemia suggests a coagulation disorder. As discussed, patients can adapt to low hemoglobin levels, such as 5 to 6 g/dL, if anemia is slow in onset.</p>
      </sec>
      <sec id="article-31596.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patient evaluation should focus on signs and symptoms of decreased oxygen delivery to tissues. Vital signs may show tachycardia and hypotension. The patient&#x02019;s mental status may be altered; cerebral infarcts may occur secondary to decreased oxygen delivery to the brain. Ischemic changes may be present on electrocardiography, and decreased urine output may be due to hypoperfusion. Laboratory studies may reveal metabolic acidosis, abnormal cardiac enzymes, or a base deficit.</p>
      </sec>
      <sec id="article-31596.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The physiologic effects of hyperbaric oxygen therapy in anemic patients are short-lived; the elevated tissue partial pressures of oxygen last only minutes to hours after each hyperbaric exposure.<xref ref-type="bibr" rid="article-31596.r5">[5]</xref> The frequency of hyperbaric oxygen therapy should be tailored to the patient&#x02019;s clinical status.<xref ref-type="bibr" rid="article-31596.r7">[7]</xref>&#x000a0;More symptomatic patients may require treatments administered two or three times daily.&#x000a0; Typically&#x000a0;treatments are at&#x000a0;2 to 3 ATA for 3&#x000a0;to 4 hours 3&#x000a0;or 4 times daily.&#x000a0; Volume status should be maintained, as well as nutritional support, folic acid, vitamin B, iron, and other hematinics.<xref ref-type="bibr" rid="article-31596.r8">[8]</xref></p>
        <p>Treatments can be administered in a monoplace (holding a single person) or multiplace (accommodating multiple people) hyperbaric chamber.&#x000a0; Treatment depths depend on the individual hyperbaric unit&#x02019;s clinical procedures.&#x000a0; Still, increased treatment depths will result in higher partial pressures of oxygen and likely increase&#x000a0;relief of the symptoms of oxygen debt.&#x000a0; Other modalities which can reduce oxygen consumption, including sedation, neuromuscular paralysis, and cooling, can also be utilized as adjunctive therapy.<xref ref-type="bibr" rid="article-31596.r9">[9]</xref> Blood should be minimized whenever possible; pediatric tubes can be used for phlebotomy to reduce unnecessary blood loss.<xref ref-type="bibr" rid="article-31596.r9">[9]</xref> Consultation with a bloodless medicine specialist for recommendations for using iron supplementation and erythropoietin may also be considered.</p>
      </sec>
      <sec id="article-31596.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differentials include the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alpha thalassemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Aplastic anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Beta thalassemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hemolytic anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Iron deficiency anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Low LDL cholesterol</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Megaloblastic anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Myelophthisic anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pernicious anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sickle cell anemia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Spur cell anemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31596.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Several case reports and series support HBO's efficacy and other "bloodless" modalities for acute and chronic blood loss anemias.<xref ref-type="bibr" rid="article-31596.r10">[10]</xref><xref ref-type="bibr" rid="article-31596.r11">[11]</xref><xref ref-type="bibr" rid="article-31596.r12">[12]</xref><xref ref-type="bibr" rid="article-31596.r13">[13]</xref></p>
      </sec>
      <sec id="article-31596.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Mild middle ear barotrauma is not uncommon.&#x000a0; Serious complications of HBO are rare.<xref ref-type="bibr" rid="article-31596.r14">[14]</xref>&#x000a0;These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Eustachian tube dysfunction</p>
          </list-item>
          <list-item>
            <p>Tympanic membrane rupture</p>
          </list-item>
          <list-item>
            <p>Oxygen toxicity</p>
          </list-item>
          <list-item>
            <p>Ear, sinus, or tooth pain</p>
          </list-item>
          <list-item>
            <p>Decompression sickness</p>
          </list-item>
          <list-item>
            <p>Pneumothorax</p>
          </list-item>
          <list-item>
            <p>Arterial gas embolism</p>
          </list-item>
          <list-item>
            <p>Nitrogen emboli to the central nervous system, lung, or joints</p>
          </list-item>
          <list-item>
            <p>Middle ear hemorrhage</p>
          </list-item>
          <list-item>
            <p>Deafness</p>
          </list-item>
          <list-item>
            <p>Changes in vision</p>
          </list-item>
          <list-item>
            <p>Certain types of hemolytic anemia</p>
          </list-item>
          <list-item>
            <p>Fire hazard</p>
          </list-item>
          <list-item>
            <p>Nausea, fatigue, malaise</p>
          </list-item>
          <list-item>
            <p>Claustrophobia</p>
          </list-item>
          <list-item>
            <p>Equipment malfunction&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31596.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Other specialists need to be involved regarding the cessation of blood loss, whether from bleeding, hemolysis, or failure of production. Reported adjunctive therapies include&#x000a0;PEGylated carboxyhemoglobin bovine, hemoglobin-based oxygen carriers, erythropoietin, steroids, and hematinics such as iron, folate, and B12/cyanocobalamin.<xref ref-type="bibr" rid="article-31596.r13">[13]</xref><xref ref-type="bibr" rid="article-31596.r8">[8]</xref><xref ref-type="bibr" rid="article-31596.r12">[12]</xref><xref ref-type="bibr" rid="article-31596.r11">[11]</xref></p>
        <p>Many hospitals have&#x000a0;Hospital Liaison Committees (HLC). These&#x000a0;can utilize community-based volunteer Jehovah&#x02019;s Witness&#x000a0;clergy that&#x000a0;assist hospitalized Jehovah&#x02019;s Witnesses. These volunteers visit patients, help coordinate care plans that reflect the spiritual beliefs of the patients, and advocate for such patients in a nonconfrontational fashion.<xref ref-type="bibr" rid="article-31596.r12">[12]</xref>&#x000a0;&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-31596.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>"The refusal of transfusion is not&#x000a0;equivalent to&#x000a0;refusing medical treatment, and numerous options are available to manage care without transfusions effectively."&#x000a0;&#x000a0;Bloodless Medicine and Surgery use&#x000a0;concepts and techniques to decrease blood loss, tolerate anemia, correct deficiencies, and otherwise manage patients without transfusions for anemia.<xref ref-type="bibr" rid="article-31596.r15">[15]</xref></p>
      </sec>
      <sec id="article-31596.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Hyperbaric oxygen therapy is generally well tolerated, and most side effects can be minimized by careful patient preparation and planning. The most common adverse event associated with hyperbaric oxygen therapy is middle ear barotrauma, which manifests as pain or pressure in the ears during chamber compression or decompression. Slow compression, pressure reduction maneuvers (such as the Valsalva maneuver), and prophylactic administration of decongestants (such as pseudoephedrine) can reduce the risk of ear barotrauma. Sinus, dental, and pulmonary barotraumas may also occur but are rarely encountered in clinical practice. Patients should avoid holding their breath during chamber ascent to reduce the risk of pulmonary barotrauma.</p>
        <p>Oxygen toxicity seizures are rare and may be minimized using scheduled air breaks. Pulmonary oxygen toxicity is rare and may be minimized by maintaining well-defined intervals of several hours between each hyperbaric treatment. Patients with diabetes may experience hypoglycemia during hyperbaric treatments, and patients with a history of claustrophobia may experience confinement anxiety.</p>
      </sec>
      <sec id="article-31596.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Awareness of HBO for blood loss anemia is low, as is access to capable HBO facilities.<xref ref-type="bibr" rid="article-31596.r16">[16]</xref>&#x000a0;Increased awareness and a willingness to transfer to an HBO-capable site can benefit anemic patients who refuse blood transfusions. They can be managed by an interprofessional team that includes clinicians, nurse practitioners and physician assistants, respiratory therapists, hyperbaric technicians, hematologists, nurses, and pharmacists. Patients should be educated that there is a potential for death without blood. Some patients may benefit from HBO therapy, but this requires multiple sessions. However, the treatment is relatively safe and cost-effective,&#x000a0;comparable in cost with&#x000a0;a unit of packed red cells.<xref ref-type="bibr" rid="article-31596.r8">[8]</xref>&#x000a0;{harmcists can provide medication reconciliation and monitor the dosing of hematinic agents, which nurses will usually administer.</p>
        <p>Often a patient wishing for treatment without blood transfusion is looked upon askance and may be marginalized. Physicians may feel compelled to offer suboptimal care, which may add to the ethical issues and risks. A&#x000a0;multidisciplinary and patient-centered approach&#x000a0;to care results in more favorable medical and psychological outcomes for the patients and their care teams.<xref ref-type="bibr" rid="article-31596.r12">[12]</xref></p>
      </sec>
      <sec id="article-31596.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31596&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31596">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/procedures/hyperbaric-therapy-in-blood-loss-anemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31596">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31596/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31596">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31596.s17">
        <title>References</title>
        <ref id="article-31596.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Meter</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach.</article-title>
            <source>Undersea Hyperb Med</source>
            <year>2005</year>
            <season>Jan-Feb</season>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-83</page-range>
            <pub-id pub-id-type="pmid">15796315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeybek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Childress</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kilic</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Pacheco</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Borahay</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>71</volume>
            <issue>8</issue>
            <fpage>488</fpage>
            <page-range>488-500</page-range>
            <pub-id pub-id-type="pmid">27526872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Meter</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>The effect of hyperbaric oxygen on severe anemia.</article-title>
            <source>Undersea Hyperb Med</source>
            <year>2012</year>
            <season>Sep-Oct</season>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>937</fpage>
            <page-range>937-42</page-range>
            <pub-id pub-id-type="pmid">23045922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BOEREMA</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>MEYNE</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>BRUMMELKAMP</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>BOUMA</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>MENSCH</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>KAMERMANS</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>STERN HANF</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van AALDEREN</surname>
              </name>
            </person-group>
            <article-title>[Life without blood].</article-title>
            <source>Ned Tijdschr Geneeskd</source>
            <year>1960</year>
            <month>May</month>
            <day>07</day>
            <volume>104</volume>
            <fpage>949</fpage>
            <page-range>949-54</page-range>
            <pub-id pub-id-type="pmid">13802034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greensmith</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen reverses organ dysfunction in severe anemia.</article-title>
            <source>Anesthesiology</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>93</volume>
            <issue>4</issue>
            <fpage>1149</fpage>
            <page-range>1149-52</page-range>
            <pub-id pub-id-type="pmid">11020776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLoughlin</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Cope</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's witness.</article-title>
            <source>Anaesthesia</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>891</fpage>
            <page-range>891-5</page-range>
            <pub-id pub-id-type="pmid">10460565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graffeo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dishong</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Severe blood loss anemia in a Jehovah's Witness treated with adjunctive hyperbaric oxygen therapy.</article-title>
            <source>Am J Emerg Med</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>756.e3</fpage>
            <page-range>756.e3-4</page-range>
            <pub-id pub-id-type="pmid">23380087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Emergency Medicine Evaluation and Management of Anemia.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>609</fpage>
            <page-range>609-630</page-range>
            <pub-id pub-id-type="pmid">30037447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutierrez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brotherton</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>205</volume>
            <issue>2</issue>
            <fpage>e5</fpage>
            <page-range>e5-8</page-range>
            <pub-id pub-id-type="pmid">21457912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson-Arbor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Verstraete</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Use of hyperbaric oxygenation as an adjunctive treatment for severe pernicious anaemia in a bloodless medicine patient.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Apr</month>
            <day>12</day>
            <volume>14</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">33846184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zumberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gorlin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dao</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Vansandt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lynn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shander</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.</article-title>
            <source>Transfusion</source>
            <year>2020</year>
            <month>May</month>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>932</fpage>
            <page-range>932-939</page-range>
            <pub-id pub-id-type="pmid">32358832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson-Arbor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Verstraete</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>No Bad Blood-Surviving Severe Anemia Without Transfusion.</article-title>
            <source>JAMA Intern Med</source>
            <year>2021</year>
            <month>Jan</month>
            <day>01</day>
            <volume>181</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-8</page-range>
            <pub-id pub-id-type="pmid">33226407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thenuwara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ibsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ituk</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nickel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goodheart</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Use of hyperbaric oxygen therapy and PEGylated carboxyhemoglobin bovine in a Jehovah's Witness with life-threatening anemia following postpartum hemorrhage.</article-title>
            <source>Int J Obstet Anesth</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>29</volume>
            <fpage>73</fpage>
            <page-range>73-80</page-range>
            <pub-id pub-id-type="pmid">27890467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy: contraindications and complications.</article-title>
            <source>J Oral Maxillofac Surg</source>
            <year>1992</year>
            <month>Oct</month>
            <volume>50</volume>
            <issue>10</issue>
            <fpage>1081</fpage>
            <page-range>1081-6</page-range>
            <pub-id pub-id-type="pmid">1356147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shander</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Javidroozi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The approach to patients with bleeding disorders who do not accept blood-derived products.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-90</page-range>
            <pub-id pub-id-type="pmid">23397555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31596.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy: its use in medical emergencies and its development in Hong Kong.</article-title>
            <source>Hong Kong Med J</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-199</page-range>
            <pub-id pub-id-type="pmid">29658485</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
